Afficher la couverture 'Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure | Joseph, Adrien' en grand format
/5

0 avis

Immune-mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure

Archive ouverte

Joseph, Adrien | Eloit, Martin | Azoulay, Elie | Kaplanski, Gilles | Provot, François | Presne, Claire | Wynckel, Alain | Grangé, Steven | Rondeau, Éric | Pène, Frédéric | Delmas, Yahsou | Lautrette, Alexandre | Barbet, Christelle | Mousson, Christiane | Coindre, Jean‐philippe | Perez, Pierre | Jamme, Matthieu | Augusto, Jean‐françois | Poullin, Pascale | Jacobs, Frédéric | El Karoui, Khalil | Vigneau, Cécile | Ulrich, Marc | Kanouni, Tarik | Le Quintrec, Moglie | Hamidou, Mohamed | Ville, Simon | Charvet‐rumpler, Anne | Ojeda‐uribe, Mario | Godmer, Pascal | Fremeaux‐bacchi, Véronique | Veyradier, Agnès | Halimi, Jean‐michel | Coppo, Paul

Edité par CCSD ; Wiley -

International audience. BACKGROUND: The prevalence, prognostic role, and diagnostic value of blood pressure in immune-mediated thrombotic thrombocytopenic purpura (iTTP) and other thrombotic microangiopathies (TMAs) remain unclear. METHODS: Using a national cohort of iTTP (n = 368), Shigatoxin-induced hemolytic uremic syndrome (n = 86), atypical hemolytic uremic syndrome (n = 84), and hypertension-related thrombotic microangiopathy (n = 25), we sought to compare the cohort’s blood pressure profile to assess its impact on prognosis and diagnostic performances. RESULTS: Patients with iTTP had lower blood pressure than patients with other TMAs, systolic (130 [interquartile range (IQR) 118-143] vs 161 [IQR 142-180] mmHg) and diastolic (76 [IQR 69-83] vs 92 [IQR 79-105] mmHg, both p < 0.001). The best threshold for iTTP diagnosis corresponded to a systolic blood pressure <150 mmHg. iTTP patients presenting with hypertension had a significantly poorer survival (hazard ratio 1.80, 95% confidence interval 1.07-3.04), and this effect remained significant after multivariable adjustment (hazard ratio = 1.14, 95% confidence interval 1.00-1.30). Addition of a blood pressure criterion modestly improved the French clinical score to predict a severe A disintegrin and metalloprotease with thrombospondin type 1 deficiency in patients with an intermediate score (i.e., either platelet count <30 × 10(9)/L or serum creatinine <200 µM). CONCLUSIONS: Elevated blood pressure at admission affects the prognosis of iTTP patients and may help discriminate them from other TMA patients. Particular attention should be paid to blood pressure and its management in these patients.

Suggestions

Du même auteur

Prognostic and Long-term Survival of Immune Thrombotic Thrombocytopenic Purpura in older patients

Archive ouverte | Prevel, Renaud | CCSD

International audience

Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Archive ouverte | Neuman, Lisa | CCSD

International audience. Background: The immune form of thrombotic thrombocytopenic purpura (iTTP) and the hemolytic and uremic syndrome (HUS) are two major forms of thrombotic microangiopathy (TMA). Their treatment ...

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

Archive ouverte | Morgand, Marjolaine | CCSD

National audience. BACKGROUND: Infectious events have been reported as major environmental triggers of thrombotic thrombocytopenic purpura (TTP). We detail here the potential association between infections and TTP. ...

Chargement des enrichissements...